Percutaneous radiofrequency ablation of hepatocellular carcinoma in the presence of portal vein thrombosis

Ziv Neeman, Steven K. Libutti, Jay W. Patti, Bradford J. Wood

Research output: Contribution to journalArticle

15 Scopus citations


Portal vein thrombosis (PVT) may not be an absolute contraindication for hepatic radiofrequency ablation (RFA). Although the data are sparse, PVT is commonly considered a contraindication to RFA. PVT has actually been described as a complication following RFA. RFA was used to treat a 3.9×2.9 cm primary hepatocellular carcinoma (HCC) in a patient with concomitant PVT without complication. RFA can be safely performed in this setting but further studies could clarify this issue.

Original languageEnglish (US)
Pages (from-to)417-420
Number of pages4
JournalClinical Imaging
Issue number6
Publication statusPublished - Jan 1 2003



  • Hepatocellular carcinoma (HCC)
  • Portal vein thrombosis (PVT)
  • Radiofrequency ablation (RFA)

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this